Patient Guide: A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 12 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05735327
Status: 🟢 Enrolling Now
Condition: Non-small Cell Lung Cancer (NSCLC)
Phase: Not Specified

Where You Can Participate

This study is available at 12 locations across the country.

Top locations include:
  • • Wroclaw, Dolnoslskie
  • • Poznan, Greater Poland Voivodeship
  • • Poznan, Greater Poland Voivodeship
  • • And 9 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY - Join Clinical Trial NCTNCT05735327

How to Join This Clinical Trial - NCTNCT05735327

Learn how to participate in this Not Specified trial studying an investigational therapy for Non-small Cell Lung Cancer (NSCLC). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-small Cell Lung Cancer (NSCLC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-small Cell Lung Cancer (NSCLC)
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05735327 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 12 locations. Find a study site near you:

Clinical Research Site

Wroclaw, Dolnoslskie 53-413 - Poland

Status: RECRUITING

Clinical Research Site

Poznan, Greater Poland Voivodeship 60-355 - Poland

Status: RECRUITING

Clinical Research Site

Poznan, Greater Poland Voivodeship 60-569 - Poland

Status: RECRUITING

Clinical Research Site

Bydgoszcz, Kuyavian-Pomeranian Voivodeship 85-796 - Poland

Status: RECRUITING

Clinical Research Site

Krakow, Lesser Poland Voivodeship 31-115 - Poland

Status: NOT_YET_RECRUITING

Clinical Research Site

Krakow, Lesser Poland Voivodeship 31-202 - Poland

Status: RECRUITING

Clinical Research Site

Lublin, Lublin Voivodeship 20-954 - Poland

Status: RECRUITING

Clinical Research Site

Warsaw, Masovian Voivodeship 01-138 - Poland

Status: RECRUITING

Clinical Research Site

Warsaw, Masovian Voivodeship 02-781 - Poland

Status: RECRUITING

Clinical Research Site

Rzeszów, Podkarpackie Voivodeship 35-241 - Poland

Status: NOT_YET_RECRUITING

And 2 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Non-small Cell Lung Cancer (NSCLC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships